ViewPoint


ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. 

We hope to revitalize the treatment paradigm for vision loss associated with presbyopia and cataracts.

Our initial focus is crystallin biology. We are addressing the global need for a non-surgical and sight-restoring treatment for cataracts and presbyopia.

Learn more about Protein Misfolding Diseases.

We are passionately committed to the discovery, development, and commercialization of treatments for protein misfolding diseases.

Learn more about Our Science.